Packaged replicons of bovine viral diarrhea virus are capable of inducing a protective immune response

Virology

Volumn 366, Issue 2, 2007, Pages 377-386

  Reimann, Ilona ^a   Semmler, Ilia ^a   Beer, Martin ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Bovine viral diarrhea virus; Pestivirus; Replicon; Trans complementation; Vaccine

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BOVINE DIARRHEA VIRUS; CALF (BOVINE); CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GENETIC TRANSFECTION; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REPLICON; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CATTLE DISEASES; CELL LINE; DIARRHEA VIRUSES, BOVINE VIRAL; GENE DELETION; HELPER VIRUSES; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIREMIA; VIRUS ASSEMBLY; VIRUS REPLICATION; VIRUS SHEDDING;

BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1; MIRIDAE; PESTIVIRUS;

EID: 34548561733     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.05.006     Document Type: Article

References (72)

1. Baker J.C. The clinical manifestations of bovine viral diarrhea infection. Vet. Clin. North Am., Food Anim. Pract. 11 (1995) 425-445
2. Becher P., Orlich M., and Thiel H.J. RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease. J. Virol. 75 (2001) 6256-6264
3. Beer M., and Wolf G. Vaccines against infection with bovine viral diarrhea virus/mucosal disease (BVDV/MD): a short overview. Berl. Munch. Tierarztl. Wochenschr. 116 (2003) 252-258
4. Beer M., Wolf G., Pichler J., Wolfmeyer A., and Kaaden O.R. Cytotoxic T-lymphocyte responses in cattle infected with bovine viral diarrhea virus. Vet. Microbiol. 58 (1997) 9-22
5. Beer M., Hehnen H.R., Wolfmeyer A., Poll G., Kaaden O.R., and Wolf G. A new inactivated BVDV genotype I and II vaccine. An immunisation and challenge study with BVDV genotype I. Vet. Microbiol. 77 (2000) 195-208
6. Behrens S.E., Grassmann C.W., Thiel H.J., Meyers G., and Tautz N. Characterization of an autonomous subgenomic pestivirus RNA replicon. J. Virol. 72 (1998) 2364-2372
7. Bolin S.R. The pathogenesis of mucosal disease. Vet. Clin. North Am., Food Anim. Pract. 11 (1995) 489-500
8. Bolin S.R., and Ridpath J.F. Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves. Am. J. Vet. Res. 56 (1995) 755-759
9. Bredenbeek P.J., Frolov I., Rice C.M., and Schlesinger S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67 (1993) 6439-6446
10. Brownlie J., Clarke M.C., and Howard C.J. Experimental production of fatal mucosal disease in cattle. Vet. Rec. 11 (1984) 535-536
11. Collen T., and Morrison W.I. CD4(+) T-cell responses to bovine viral diarrhoea virus in cattle. Virus Res. 67 (2000) 67-80
12. Collett M.S., Larson R., Belzer S.K., and Retzel E. Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus. Virology 165 (1988) 200-208
13. Collett M.S., Moennig V., and Horzinek M.C. Recent advances in pestivirus research. J. Gen. Virol. 70 (1989) 253-266
14. Donis R.O. Molecular biology of bovine viral diarrhea virus and its interactions with the host. Vet. Clin. North Am., Food Anim. Pract. 11 (1995) 393-423
15. Donis R.O., Corapi W., and Dubovi E.J. Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56 K to 58 K glycoprotein. J. Gen. Virol. 69 (1988) 77-86
16. Edwards S., Sands J.J., and Harkness J.W. The application of monoclonal antibody panels to characterize pestivirus isolates from ruminants in Great Britain. Arch. Virol. 102 (1988) 197-206
17. Edwards S., Moennig V., and Wensvoort G. The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses. Vet. Microbiol. 29 (1991) 101-108
18. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus Taxonomy, VIIIth Report of the ICTV (2005), Elsevier/Academic Press, London
19. Fernelius A.L., Classick L.G., and Smith R.L. Evaluation of a soluble antigen vaccine prepared from bovine viral diarrhea-mucosal diseases virus-infected cell cultures. Am. J. Vet. Res. 32 (1971) 1963-1979
20. Frey C.F., Bauhofer O., Ruggli N., Summerfield A., Hofmann M.A., and Tratschin J.D. Classical swine fever virus replicon particles lacking the E(rns) gene: a potential marker vaccine for intradermal application. Vet. Res. 37 (2006) 655-670
21. Frolov I., Hoffman T.A., Pragai B.M., Dryga S.A., Huang H.V., Schlesinger S., and Rice C.M. Alphavirus-based expression vectors: strategies and applications. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11371-11377
22. Gehrke R., Ecker M., Aberle S.W., Allison S.L., Heinz F.X., and Mandl C.W. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J. Virol. 77 (2003) 8924-8933
23. Gehrke R., Heinz FX., Davis N.L., and Mandl C.W. Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon. J. Gen. Virol. 86 (2005) 1045-1053
24. Grassmann C.W., Isken O., Tautz N., and Behrens S.E. Genetic analysis of the pestivirus nonstructural coding region: defects in the NS5A unit can be complemented in trans. J. Virol. 75 (2001) 791-802
25. Grummer B., Beer M., Liebler-Tenorio E., and Greiser-Wilke I. Localization of viral proteins in cells infected with bovine viral diarrhoea virus. J. Gen. Virol. 82 (2001) 2597-2605
26. Harada T., Tautz N., and Thiel H.J. E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies. J. Virol. 74 (2000) 9498-9506
27. Harvey T.J., Liu W.J., Wang X.J., Linedale R., Jacobs M., Davidson A., Le T.T.T., Anraku I., Suhrbier A., Shi P.Y., and Khromykh A.A. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 78 (2004) 531-538
28. Houe H. Epidemiology of bovine viral diarrhea virus. Vet. Clin. North Am., Food Anim. Pract. 11 (1995) 521-547
29. Howard C.J., Clarke M.C., Sopp P., and Brownlie J. Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet. Microbiol. 42 (1994) 171-179
30. Khromykh A.A., Varnavski A.N., and Westaway E.G. Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J. Virol. 72 (1998) 5967-5977
31. Khromykh A.A., Sedlak P.L., Guyatt K.J., Hall R.A., and Westaway E.G. Efficient trans-complementation of the flavivirus kunjin NS5 protein but not of the NS1 protein requires its coexpression with other components of the viral replicase. J. Virol. 73 (1999) 10272-10280
32. Kümmerer B.M., and Meyers G. Correlation between point mutations in NS2 and the viability and cytopathogenicity of bovine viral diarrhea virus strain Oregon analyzed with an infectious cDNA clone. J. Virol. 74 (2000) 390-400
33. Kupfermann H., Thiel H.J., Dubovi E.J., and Meyers G. Bovine viral diarrhea virus: characterization of a cytopathogenic defective interfering particle with two internal deletions. J. Virol. 70 (1996) 8175-8181
34. Lackner T., Müller A., Pankraz A., Becher P., Thiel H.J., Gorbalenya A.E., and Tautz N. Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus. J. Virol. 78 (2004) 10765-10775
35. Lackner T., Müller A., König M., Thiel H.J., and Tautz N. Persistence of bovine viral diarrhea virus is determined by a cellular cofactor of a viral autoprotease. J. Virol. 79 (2005) 9746-9755
36. Lee Y.M., Tscherne D.M., Yun S.I., Frolov I., and Rice C.M. Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J. Virol. 79 (2005) 3231-3242
37. Lindenbach B.D., and Rice C.M. Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71 (1997) 9608-9617
38. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
39. Liu W.J., Sedlak P.L., Kondratieva N., and Khromykh A.A. Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly. J. Virol. 76 (2002) 10766-10775
40. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., and Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285 (1999) 110-113
41. Mandl C.W. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers. Viral Immunol. 17 (2004) 461-472
42. Mason P.W., Shustov A.V., and Frolov I. Production and characterization of vaccines based on flaviviruses defective in replication. Virology 351 (2006) 432-443
43. Maurer R., Stettler P., Ruggli N., Hofmann M.A., and Tratschin J.D. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV. Vaccine 23 (2005) 3318-3328
44. Meyers G., and Thiel H.J. Cytopathogenicity of classical swine fever virus caused by defective interfering particles. J. Virol. 69 (1995) 3683-3689
45. Meyers G., Tautz N., Becher P., Thiel H.J., and Kümmerer B.M. Recovery of cytopathogenic and noncytopathogenic bovine viral diarrhea viruses from cDNA constructs. J. Virol. 70 (1996) 8606-8613
46. Meyer C., von Freyburg M., Elbers K., and Meyers G. Recovery of virulent and RNase-negative attenuated type 2 bovine viral diarrhea viruses from infectious cDNA clones. J. Virol. 76 (2002) 8494-8503
47. Mittelholzer C., Moser C., Tratschin J.D., and Hofmann M.A. Generation of cytopathogenic subgenomic RNA of classical swine fever virus in persistently infected porcine cell lines. Virus Res. 51 (1997) 125-137
48. Moennig V., and Liess B. Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet. Clin. North Am., Food Anim. Pract. 11 (1995) 477-487
49. Moennig V., Eicken K., Flebbe U., Frey H.R., Grummer B., Haas L., Greiser-Wilke I., and Liess B. Implementation of two-step vaccination in the control of bovine viral diarrhoea (BVD). Prev. Vet. Med. 72 (2005) 109-114
50. Moormann R.J., van Gennip H.G., Miedema G.K., Hulst M.M., and van Rijn P.A. Infectious RNA transcribed from an engineered full-length cDNA template of the genome of a pestivirus. J. Virol. 7 (1996) 763-770
51. Moser C., Ruggli N., Tratschin J.D., and Hofmann M.A. Detection of antibodies against classical swine fever virus in swine sera by indirect ELISA using recombinant envelope glycoprotein E2. Vet. Microbiol. 51 (1996) 41-53
52. Nam J.H., Bukh J., Purcell R.H., and Emerson S.U. High-level expression of hepatitis C virus (HCV) structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype. J. Virol. Methods 97 (2001) 113-123
53. Overby L.R., Bradley D.W., and Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359-362
54. Peters W., Greiser-Wilke I., Moennig V., and Liess B. Preliminary serological characterization of bovine viral diarrhoea virus strains using monoclonal antibodies. Vet. Microbiol. 12 (1986) 195-200
55. Pijlman G.P., Suhrbier A., and Khromykh A.A. Kunjin virus replicons, an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opin. Biol. Ther. 6 (2006) 135-145
56. Pijlman G.P., Kondratieva N., and Kromykh A.A. Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging. J. Virol. 80 (2006) 11255-11264
57. Potgieter LN. Immunology of bovine viral diarrhea virus. Vet. Clin. North Am., Food Anim. Pract. 11 (1995) 501-520
58. Reimann I., Meyers G., and Beer M. Trans-complementation of autonomously replicating bovine viral diarrhea virus replicons with deletions in the E2 coding region. Virology 307 (2003) 213-227
59. Reimann I., Depner K., Trapp S., and Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 322 (2004) 143-157
60. Rüggli N., Tratschin J.D., Mittelholzer C., and Hofmann M.A. Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA. J. Virol. 70 (1996) 3478-3487
61. Rümenapf T., Stark R., Meyers G., and Thiel H.J. Structural proteins of hog cholera virus expressed by vaccinia virus, further characterization and induction of protective immunity. J. Virol. 65 (1991) 589-597
62. Rümenapf T., Unger G., Strauss J.H., and Thiel H.J. Processing of the envelope glycoproteins of pestiviruses. J. Virol. 67 (1993) 3288-3294
63. Schlesinger S., and Dubensky T.W. Alphavirus vectors for gene expression and vaccines. Curr. Opin. Biotechnol. 10 (1999) 434-439
64. Scholle F., Girard Y.A., Zhao Q., Higgs S., and Mason P.W. Trans-packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 78 (2004) 11605-11614
65. Thiel H.J., Stark R., Weiland E., Rümenapf T., and Meyers G. Hog cholera virus: molecular composition of virions from a pestivirus. J. Virol. 65 (1991) 4705-4712
66. Thierauf, P., 1993. Untersuchungen zur Epidemiologie, Diagnose und Immunprophylaxe von BVD/MD - Virusinfektionen in Milchviehzuchtbeständen. DVM Thesis, Munich.
67. pro is not required for viral replication in cell culture. J. Virol. 72 (1998) 7681-7684
68. van Gennip H.G., van Rijn P.A., Widjojoatmodjo M.N., de Smit A.J., and Moormann R.J. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 19 (2000) 447-459
69. van Gennip H.G., Bouma A., van Rijn P.A., Widjojoatmodjo M.N., and Moormann R.J. Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. Vaccine 20 (2002) 1544-1556
70. Weiss B.G., and Schlesinger S. Recombination between Sindbis virus RNAs. J. Virol. 65 (1991) 4017-4025
71. Widjojoatmodjo M.N., van Gennip H.G., Bouma A., van Rijn P.A., and Moormann R.J. Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccines. J. Virol. 74 (2000) 2973-2980
72. Wolfmeyer A., Wolf G., Beer M., Strube W., Hehnen H.R., Schmeer N., and Kaaden O.R. Genomic (5′UTR) and serological differences among German BVDV field isolates. Arch. Virol. 142 (1997) 2049-2057